Can science fiction help us grapple with gene editing?

Nov 29, 2018
You had to know we were going to talk about "Gattaca."
Mario Tama/Getty Images

Who owns the results of genetic testing?

Oct 16, 2018
Personal data from genetic tests has been used in drug development and research.
A visitor views a digital representation of the human genome in 2001 at the American Museum of Natural History in New York City.
Mario Tama/Getty Images

Who owns the results of genetic testing?

Oct 16, 2018
Personal data from genetic tests has been used in drug development and research.
A visitor views a digital representation of the human genome in 2001 at the American Museum of Natural History in New York City.
Mario Tama/Getty Images

Crispr inventor worries about the unintended consequences of gene editing

Jun 16, 2017
Jennifer Doudna says the real value in the technology is that it 'opens up opportunities for applications.'
DOE Joint Genome Institute via VisualHunt

Our most immutable material

Mar 16, 2016
23andMe’s Kate Black on protecting genetic data.
23andMe provides genetics testing to customers. 
23andMe/Youtube

23andMe is jumping back into the market

Oct 21, 2015
The company will offer tests to determine if people are carriers relatively rare diseases.

Promoting health at the molecular level

Aug 12, 2015
When wellness starts with a genome sequence.

You’ve got questions. We help you answer them.

Support nonprofit, independent journalism that makes you smarter.

23andMe believes genetics are the future of health

Jul 6, 2015
CEO Anne Wojcicki wants to improve drug therapies by using DNA data.

Genetics may be the next big thing in medicine, but at what cost?

Apr 12, 2013
Many believe genetics are the next big thing in medicine, but one question for this new era of personalized medicine is cost.

The growth of the genetic testing industry

Mar 12, 2012
A new study that predicts that Americans could be spending $25 billion a year by the end of this decade on genetics testing. It's believed that the prospect of being able to sequence whole genomes at an affordable cost now is really a gamechanger.